Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
January 20, 2021

Novartis, GSK team up for $3.6m genetic diversity research in Africa

Swiss pharma giant Novartis and British pharmaceuticals company GSK have teamed up to conduct scientific research linking genetic diversity in Africa and its potential impact on response to drug therapeutics.

The project aims to support research on genetic diversity and drug responses in Africa. (Credit: Silesia711/Wikipedia.org.)